Literature DB >> 3628520

Effect of naltrexone on food intake, hunger, and satiety in obese men.

T A Spiegel, A J Stunkard, E E Shrager, C P O'Brien, M F Morrison, E Stellar.   

Abstract

Increasing doses of naltrexone (25 to 200 mg) given over 4 consecutive days reduced intake of laboratory luncheon meals by 30% in 17 obese men. Meal size remained suppressed in the laboratory during the week following naltrexone administration. Water intake in the laboratory and body weight were not affected. Rates of ingestion and subjective ratings suggested that naltrexone reduced appetite rather than promoted early satiation. Nausea and other side effects occurred on 1 or 2 days during the naltrexone week in seven subjects whose food intake was reduced. Food intake was also reduced in seven of the remaining 10 subjects who reported no adverse reactions. These results suggest that a conditioned taste aversion or a conditioned anorexia may have developed in some subjects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3628520     DOI: 10.1016/0031-9384(87)90198-3

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  11 in total

1.  Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals.

Authors:  Samuel R Chamberlain; Karin Mogg; Brendan P Bradley; Annelize Koch; Chris M Dodds; Wenli X Tao; Kay Maltby; Bhopinder Sarai; Antonella Napolitano; Duncan B Richards; Edward T Bullmore; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2012-07-03       Impact factor: 4.530

2.  Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.

Authors:  Frederick M Hecht; Jennifer Daubenmier; Elissa S Epel; Ashley E Mason; Robert H Lustig; Rashida R Brown; Michael Acree; Peter Bacchetti; Patricia J Moran; Mary Dallman; Barbara Laraia; Nancy Adler
Journal:  Appetite       Date:  2015-04-27       Impact factor: 3.868

3.  Effects of nalmefene on feeding in humans. Dissociation of hunger and palatability.

Authors:  M R Yeomans; P Wright; H A Macleod; J A Critchley
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  The relationship between opioid and sugar intake: review of evidence and clinical applications.

Authors:  David J Mysels; Maria A Sullivan
Journal:  J Opioid Manag       Date:  2010 Nov-Dec

Review 5.  Pharmacological management of appetite expression in obesity.

Authors:  Jason C G Halford; Emma J Boyland; John E Blundell; Tim C Kirkham; Joanne A Harrold
Journal:  Nat Rev Endocrinol       Date:  2010-03-16       Impact factor: 43.330

6.  Putting the brakes on the "drive to eat": Pilot effects of naltrexone and reward-based eating on food cravings among obese women.

Authors:  Ashley E Mason; Barbara Laraia; Jennifer Daubenmier; Frederick M Hecht; Robert H Lustig; Eli Puterman; Nancy Adler; Mary Dallman; Michaela Kiernan; Ashley N Gearhardt; Elissa S Epel
Journal:  Eat Behav       Date:  2015-07-02

Review 7.  The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics.

Authors:  Rebecca G Boswell; Marc N Potenza; Carlos M Grilo
Journal:  Clin Ther       Date:  2020-11-27       Impact factor: 3.393

8.  Pharmacotherapies for obesity: past, current, and future therapies.

Authors:  Lisa L Ioannides-Demos; Loretta Piccenna; John J McNeil
Journal:  J Obes       Date:  2010-12-12

Review 9.  Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date.

Authors:  Assumpta Caixàs; Lara Albert; Ismael Capel; Mercedes Rigla
Journal:  Drug Des Devel Ther       Date:  2014-09-18       Impact factor: 4.162

10.  Effects of Opioid Antagonism on Cerebrospinal Fluid Melanocortin Peptides and Cortisol Levels in Humans.

Authors:  Rebecca J Gordon; Sunil K Panigrahi; Kana Meece; Deniz Atalayer; Richard Smiley; Sharon L Wardlaw
Journal:  J Endocr Soc       Date:  2017-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.